Skip to main content
. 2016 May 9;37(5):423–434. doi: 10.1177/0333102416649092

Table 1.

Summary of the patients (n = 10) who were not eligible to participate in the long-term follow-up study.

Reason not invited to participate in long-term follow-up study Therapeutic response during open-label period
Study not initiated at site (n = 1) Frequency (n = 1)
Non-compliant: would not show up for clinic visits (n = 3) Frequency (n = 3)
Non-compliant: would not follow site instructions (n = 1) Frequency (n = 1)
Non-compliant: would not apply stimulation as directed (n = 1) Non-responder (n = 1)
Did not meet inclusion criteria – did not have microstimulator still implanted (n = 4) Not evaluable (n = 4)

Therapeutic responses during the open-label period of the Pathway CH-1 study are provided.